Pfanstiehl can provide full technical as well as regulatory support for our products incld. DMF filings in USA as well as in China and has tremendous manufacturing capacity for these critical biopharma ingredients.  All of Pfanstiehl’s products are multi-compendial and having industry leading quality specifications. Pfanstiehl has been in operation since 1919, focusing on both Biopharmaceutical excipients / critical components & Pharmaceutical HPAPIs / APIs (generic and on contract manufacturing base). Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, in gram to multi-ton commercial quantities.